argenx SE

argenx SEverified

ARGX.BR

Price:

$485.5

Market Cap:

$32.30B

argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, and chronic inflammatory demyelinating polyneuropathy in Phase III clinical trials; bullous pemphigoid and idiopathic inflammatory myopathy in Phase II/III clinical trials; and ENHANZE SC in Pre-clinical study. The company is also developing immunology innovation programs, including cusatuzumab for hematological cancer, as well as high risk MDS; ARGX-...[Read more]

Industry

Biotechnology

IPO Date

2014-07-10

Stock Exchange

EURONEXT

Ticker

ARGX.BR

The Current Ratio as of September 2024 (TTM) for argenx SE (ARGX.BR) is 8.53

According to argenx SE’s latest financial reports and current stock price. The company's current Current Ratio is 8.53. This represents a change of 86.71% compared to the average of 4.57 of the last 4 quarters.

argenx SE (ARGX.BR) Historical Current Ratio (quarterly & annually)

How has ARGX.BR Current Ratio performed in the past?

The mean historical Current Ratio of argenx SE over the last ten years is 8.49. The current 8.53 Current Ratio has changed 9.95% with respect to the historical average. Over the past ten years (40 quarters), ARGX.BR's Current Ratio was at its highest in in the December 2018 quarter at 14.29. The Current Ratio was at its lowest in in the September 2014 quarter at 0.

Quarterly (TTM)
Annual

Average

8.49

Median

8.51

Minimum

2.40

Maximum

14.29

argenx SE (ARGX.BR) Current Ratio by Quarter and Year

Discovering the peaks and valleys of argenx SE Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 488.68%

Maximum Annual Current Ratio = 14.29

Minimum Annual Increase = -52.76%

Minimum Annual Current Ratio = 2.40

Quarterly (TTM)
Annual
YearCurrent RatioChange
20239.756.22%
20229.188.72%
20218.4434.81%
20206.26-27.06%
20198.58-39.93%
201814.291.11%
201714.13488.68%
20162.40-52.76%
20155.08-25.34%
20146.81-7.78%

argenx SE (ARGX.BR) Average Current Ratio

How has ARGX.BR Current Ratio performed in the past?

The current Current Ratio of argenx SE (ARGX.BR) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

9.12

5-year avg

8.44

10-year avg

8.49

argenx SE (ARGX.BR) Current Ratio vs. Peers

How is ARGX.BR’s Current Ratio compared to its peers?

argenx SE’s Current Ratio is less than Galapagos NV (10.05), greater than Mithra Pharmaceuticals SA (0.90), greater than UCB SA (1.19), greater than Biocartis Group NV (2.15), greater than Melexis NV (4.70),

CompanyCurrent RatioMarket cap
10.05$1.79B
0.90$14.93M
1.19$31.20B
2.15$27.24M
4.70$3.07B

Build a custom stock screener for argenx SE (ARGX.BR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like argenx SE using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

argenx SE (ARGX.BR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like argenx SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is argenx SE's Current Ratio?

How is the Current Ratio calculated for argenx SE (ARGX.BR)?

What is the highest Current Ratio for argenx SE (ARGX.BR)?

What is the 3-year average Current Ratio for argenx SE (ARGX.BR)?

What is the 5-year average Current Ratio for argenx SE (ARGX.BR)?

How does the current Current Ratio for argenx SE (ARGX.BR) compare to its historical average?